This is a preview of subscription content, log in via an institution to check access.
Notes
see Reactions 1595 p3; 803177765 and see Reactions 1602 p3; 803185187
Reference
Health Canada. Summary Safety Review - Zydelig (idelalisib) - Assessing the potential risk of serious infections. Internet Document : 3 Mar 2017. Available from: URL: http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/zydelig-eng.php
Rights and permissions
About this article
Cite this article
Risk of serious infections with idelalisib: labelling update. Reactions Weekly 1643, 3 (2017). https://doi.org/10.1007/s40278-017-27476-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-27476-6